Cite

HARVARD Citation

    Zhang, S. et al. (2018). Efficacy of concurrent chemoradiotherapy combined with nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma. Medicine. 97 (38), p. . [Online]. 
  
Back to record